Anika Therapeutics, Inc.
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|
| Revenue | $43.6M | $35.2M | $27.4M | $23.4M |
| Joint Preservation and Restoration | $0 | $0 | $0 | $0 |
| Other Joint Pain Management | $38.6M | $31.5M | $25.1M | $21.2M |
| Non-Orthopedic | $5.0M | $3.7M | $2.3M | $2.2M |
| Cost of Revenue | $13.7M | — | — | — |
| Gross Profit | $29.9M | — | — | — |
| Gross Margin | 68.7% | — | — | — |
| Operating Expenses | ||||
| Research & Development | $8.2M | — | — | — |
| SG&A Expense | $10.5M | — | — | — |
| Operating Income | $5.6M | — | — | — |
| Operating Margin | 12.8% | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | $5.5M | — | — | — |
| Income Tax Expense | $1.8M | — | — | — |
| Net Income | $3.7M | — | — | — |
| Net Margin | 8.5% | — | — | — |
| EPS (Basic) | $0.32 | — | — | — |
| EPS (Diluted) | $0.32 | — | — | — |
| Shares Outstanding (Basic) | 11.4M | — | — | — |
| Shares Outstanding (Diluted) | 11.6M | — | — | — |
| Dividends Per Share | — | — | — | — |